Landeskrankenanstalten-Betriebsgesellschaft Kabeg

The medical center is at the forefront of gastroenterology research, focusing on innovative treatments for Crohn's Disease. The center's work aims to improve patient outcomes by evaluating new therapeutic agents that target disease activity and remission.

• Crohn's Disease Activity Index (CDAI) Remission

Through rigorous clinical trials, the center is advancing the understanding of inflammatory bowel diseases and enhancing therapeutic strategies.

Specializing in oncology, the center conducts pivotal research in multiple myeloma and various forms of liver cancer, including hepatocellular carcinoma. The focus is on developing combination therapies that improve survival rates and quality of life for cancer patients.

• Multiple Myeloma
• Hepatocellular Carcinoma
• Non-Small Cell Lung Cancer

By integrating immunotherapy and targeted treatments, the center is leading efforts to combat cancer more effectively.

The center is renowned for its research in hepatology, particularly in addressing Non-Alcoholic Steatohepatitis (NASH) and liver diseases associated with genetic conditions. The goal is to halt disease progression and improve liver function through novel therapeutic approaches.

• Non-Alcoholic Steatohepatitis (NASH)
• Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

Innovative clinical trials are paving the way for new treatments that could significantly alter the course of liver diseases.

In the realm of cardiology and hematology, the center is exploring advanced therapies for conditions like acute major bleeding in patients on anticoagulant therapy. The research focuses on improving hemostatic effectiveness and patient safety.

• Acute Major Bleeding

These studies are crucial for developing safer and more effective treatment protocols for patients with bleeding disorders.

The center's research in respiratory medicine includes studies on lung safety and function, particularly in patients with genetic liver diseases that affect the lungs. This research is vital for understanding the systemic impact of these conditions.

• Alpha-1 Antitrypsin Deficiency

By focusing on long-term safety and tolerability, the center aims to improve the quality of life for patients with complex respiratory conditions.

Leading the way in digital health, the center is investigating the impact of digital solutions on health outcomes and resource utilization. This research is transforming how patients are monitored and treated in clinical practice.

• Digital Patient Monitoring

By integrating technology into healthcare, the center is enhancing patient care and optimizing treatment pathways.